Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: Current clinical evidence and therapeutic potential of rapastinel (GLYX-13)

Andrei Nicolae Vasilescu, Nina Schweinfurth, Stefan Borgwardt, Peter Gass, Undine E. Lang*, Dragos Inta, Sarah Eckart

*Corresponding author for this work
16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: Current clinical evidence and therapeutic potential of rapastinel (GLYX-13)'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science